Healthcare Social Media and Updates
Healthcare Social Media and Updates
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Now in addition to our @TexasChildrens @BCM_TropMed protein vaccines for global health, our scientists are refining the mRNA technology for new immunotherapies for pancreatic cancer and triple negative breast cancer, if only the grant support would hold… https://t.co/NEgq6DX4qz
One of the most clarifying conversations we've had about where biotech should go next. Krish Ramadurai of @aixventureshq argues interpretability is the new scalability, and that the founders who build mechanistic, measurable platforms will define the next era of synthetic biology. He...
Investor Liliana Nordbakk believes the genome behaves like code and AI-native biology platforms will transform biotech. Excited to have her speaking at #SynBioBeta2026. Visit the SynBioBeta website to read the full article. https://t.co/3WOSXsz1zy
The Relationships between physical activity, sedentary behaviour, sleep, and dementia: A systematic review and meta-analysis of cohort studies "Regular physical activity significantly reduced the risk of incident dementia (pooled RR = 0.75... Prolonged sedentary behaviour (8 + hours/day sitting) increased dementia risk (RR = 1.27)... both short (8 hours;...
Investing in hope A wealthy family fighting its own disease boosted research.. Can it spur new dementia treatments? 🗣️"Here was this beautiful family that really wanted to find a cure. And none of us scientists wanted to let them down." https://t.co/DBmpjpkxkl
.@peteratmsr on why AI could shift healthcare away from subspecialties, and toward a supercharged version of general practice. Catch my episode with Peter (President of Microsoft Science) on Lifers: Apple: https://t.co/e5WslnfSee Spotify: https://t.co/TaqlqEsE3f YouTube: https://t.co/eAaMF0XEiB
With Kymera in the news today, reposting this cool little known fact about them that I learned on a prior visit. https://t.co/ctlvveAlJZ
Reprogramming of cells via a 3D printed scaffold and extracellular vesicles substantially enhances bone regeneration https://t.co/w6AyvguUjS https://t.co/R32ULM1Rzt
Chasing a tough-to-treat lung disease, Avalyn plans an IPO https://t.co/743svTKTS4 by @gwendolynawu #IPO $AVLN $BMY $ABBV
Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk https://t.co/zM6udFvuNE by Kristin Jensen $LLY $NVO #obesity
Interoperability wins come in all shapes and sizes. This week's shape is... tractor? John Deere just agreed to a $99 million right-to-repair settlement that includes a 10-year court-supervised mandate to open its diagnostic tooling to farmers and independent repair shops. The...
More success for rebooting B cells towards cure of different autoimmune diseases beyond lupus, MS and others https://t.co/sFGMiFeiEF https://t.co/Dbvca9eox8
Venetoclax in myeloma: t(11;14) and what else? {Commentary} [Apr 2, 2026] Catherine Pellat-Deceunynck @BloodPortfolio https://t.co/Zar26htoUT #mmsm #PrecisionMedicine https://t.co/zm0Fv6GY2l
The Trump administration has voiced some tough rhetoric about health insurers. But almost every major decision from Trump officials has benefited insurers and their bottom lines. The new Medicare Advantage rule is the latest example. https://t.co/ziGzSwknqK https://t.co/N3ACGahj3C
what a timeline - Sept. 1999 - $GSK withdraws Wellcovorin (leucovorin) bc it's not selling Sept. 2025 - GSK is told by FDA to apply for a new indication for leucovorin after an FDA review of lit. March 2026 - FDA approves...
Your clinical trial baseline is a mix of liver mets, lung mets, bone mets, and primary tumors. You compare it to post-treatment samples from different sites. The "treatment effects" you find will mostly be tissue site differences. https://t.co/0PyjMM2Znl
As a medical school professor, I tell my students: intensity matters more than duration. A massive 7-year study of 96,000 adults just proved it. Published in the European Heart Journal, the findings are striking: People who did just 15-20 minutes of vigorous activity...
My comments and interview with @Medscape Next-Gen Yellow Fever Vaccine Hits the Mark in Mid-Stage Trial https://t.co/kFfGH4c5gt
What if we started thinking of mRNA-CRISPR gene editing as molecular surgery, not as a pharmaceutical product? Excellent @nytimes guest essay ⤵️ https://t.co/S61XwNRVZF
David Sinclair says rapamycin had no measurable effect on slowing or reversing epigenetic aging in humans. This was a drug most of the longevity community supported. He was even a believer of it. It was found to extend lifespan in: • Inbred lab animals •...
No surgeon. No anesthesiologist. One physician. Packed ED. @jessicasinghmd stabilized a critically ill patient with blood in their airway. Shift ends. The incoming physician, also an administrator, says in front of staff: "I need you to function." She reported it....
A 10-year study finds weight-loss drugs lower the risk of #depression and anxiety. Published in The Lancet Psychiatry, the #research revealed a 42% lower risk of #mentalhealth hospitalisation during periods of semaglutide use. https://t.co/CphnQl0Khx
Every now and then, remarkable breakthroughs come with a dash of ‘why didn’t I think of that?’ ingenuity. From reimagined everyday objects to solutions inspired by the natural world, these innovations prove that effective healthcare doesn’t always need to be...
Targeting the Biology of Aging in Cerebrovascular Disease: Inflammation, Metabolism, Senescence, and Regeneration 🔎Addressing age-specific pathophysiology will be critical for improving outcomes in cerebrovascular diseases in the aging population... https://t.co/DuScTnSIh5 https://t.co/Irok29jqMx
I recently had the opportunity to sit down with Scott Carney for a wide-ranging conversation on regenerative medicine, stem cells, peptides, and the growing gap between scientific promise and clinical reality. In the conversation, we dig into: – Why stem cell therapies...
The US spends more on healthcare than any country on earth. The national average life expectancy is 77.5. Mississippi is 72.6. Source: Visual Capitalist https://www.visualcapitalist.com/mapped-us-life-expectancy-by-state/
Why physicians pay more in taxes and how to reclaim your income [PODCAST] http://dlvr.it/TRxTZR Podcast #PracticeManagement
This is why nursing is a great career choice. My wife was making good money at 21. In a major city hospital, you can easily make $80,000+ on 40 hours/week (on a side note, her income was the only way I...
Wish you could hear everything around you, whether you're at a noisy restaurant or just watching TV at home? I check out the Cearvol Nano OTC Hearing Aids in various locations and find it's a great way to turn up...
JUST IN: Scientists built bacteria that EATS cancer from the inside out. The future of cancer treatment isn't a drug. It's a living organism that devours tumors from the inside. Here's how it works: Solid tumors have a dead center. No oxygen. No...
Genflow sees sustained safety and efficacy in SIRT6 beagle trial 🐶 “Genflow Biosciences reported that three-month follow-up data from its SLAB trial in aged beagles show sustained safety and efficacy of its SIRT6 centenarian gene therapy, with no adverse events and...
Should older adults use statins for heart health? Do statins increase the risk of diabetes and Alzheimer's Disease? Dr. Gregory Charlop shares the results of an important new health study. www.buckheadlongevity.com/blog/should-older-adults-use-statins-a-top-atlanta-longevity-doctor-answers
More hearing aids? Yes, because lots of folks have mild hearing loss, and OTC solutions are affordable and, honestly, game changing. This time I'm looking at the new Techmi FacePro OTC Hearing Aids in this demo and review: https://t.co/W0GUOshVxw #hearing...
EAA241 - Ph 2 RCT Dara-Bor-Dex vs Cy-Bor-Dex in the treatment of Newly Diagnosed Multiple Myeloma with Light Chain Cast Nephropathy (LCCN) [Study activated 8/11/25] @keruakous https://t.co/1NgvVZ3fTA #NCT07085728 #mmsm @eaonc https://t.co/18HJ5kRuNj
#EAOnc EQUATE EAA181 Effective Quadruplet Utilization After Tx Evaluation: Ph3 RCT NDMM Not Intended for Early ASCT [Activated: 10/27/20] PI= @myelomaMD https://t.co/qD26HMx3J8 #NCT04566328 #mmMRD #mmsm @eaonc @mweissmdphd @VincentRK @LynneWagnerPhD Wei Snyder Kostakoglu @mtmdphd
GENE THERAPY SAFELY ERADICATES BRAIN TUMOURS IN MICE A single dose of an innovative gene therapy could eliminate hard-to-treat brain tumours and prevent them from coming back, according to a pre-clinical trial in mice, reported in Nature. “More than 80 per cent...
OHSU Knight Cancer Institute receives record $2 billion commitment from Phil and Penny Knight https://t.co/5rgDVaDUtv
A Durable and High-Performance Bionic Prosthetic Built for Real-World Use by @COVVI #Robotics #Innovation #EmergingTech #TechForGood #Technology https://t.co/9XKhPrkA8c
Can rebooting the diet, eliminating 2 essential amino acids, help treat an aggressive brain cancer in children? mechanism and potential established from experimental model https://t.co/wmAFM2ErRB https://t.co/PAOr5SL30y
Should people over age 80 use statins? The answer is increasingly: YES. A recent study found that patients over 80 on statins had a one-third reduction in mortality. Perhaps more telling, people who stopped their statins appeared to have a 1/3...
💉 Want to reduce the risk of Alzheimer' by 55%? A simple flu shot at the dosage recommended by the CDC for those 65 and older should do the trick. With 165,000 people in the study, they also...
AI Drug Discovery – Revolution or Expensive Illusion? | Ep. 978 https://t.co/YLQ8QNlnWv [ 00:34 ] Billions into AI drug discovery [ 01:04 ] AI doesn’t cure diseases [ 01:38 ] Expensive illusion vs reality [ 02:23 ] Original pitch inefficiency problem [ 03:48 ] Only 10...
Jim and Karen Ansara have invested deeply in creating healthcare facilities in Haiti and other countries, with growing impact. Guest Contributor, Susan Barnett Reports: https://tinyurl.com/yc6e924m GlobalHealth
‘We Were Not Ready for This’: Lebanon's Emergency System Is Hanging by a Thread https://t.co/dAYb1KGaD0 https://t.co/W11udn08dy
A new catalytic method enables rapid, selective synthesis of branched molecules from simple, inexpensive reagents, streamlining early drug discovery and expanding access to complex molecular architectures. drugdiscovery
If anyone can build a GLP-1 company for $50K, what actually separates the winners? I asked Josh Tauber and @keatonbedell on Lifers, their answer: not software. Trust. WATCH/LISTEN: Spotify: https://t.co/hrs0ZbILVz Apple: https://t.co/e8IxsoZ2bB Youtube: https://t.co/ORjNyzcOli
When cancer is found early, the chances for a cure are dramatically higher. The controversial part: most people never look. Don't wait for symptoms.
A couple cool cancer drug startups profiled this week in TR. Sidewinder Therapeutics with $137M for bispecific ADCs https://t.co/tJcQwI7C4U and Stipple Bio with $100M for novel targets for antibody drugs. https://t.co/rbXkuaRpoe
You'll never guess which of these two dosing intervals Wedbush says "may not be viable" for $NKTR Rezpeg moving forward. Won't mince words - This firm is responsible for the worst sellside work I've ever seen. Sorry to be harsh,...
No cause and effect established, but the more optimism the less dementia in >9,000 individuals with up to 14 year follow-up https://t.co/8pTnuJ9XSF https://t.co/Lcg4uExYrO
